CRAF
AMENDMENT CORRESPONDENCE ENTERED
01/07/2025
Back to search
Official data from USPTO
HISUNUSA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
01/07/2025
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
07/31/2022
Registration date
09/26/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2023
Last transaction
01/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
02/11/1998
First use in commerce
2009-11-00
Drawing code
3
Owner type
99
Owner location
Zhejiang, CN
Examiner
VANDZHURA, EMILIA
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized wording of "HISUNUSA" with letters "HISUN" in black color and letters "USA" in blue color. To the left of "HISUNUSA" there is a square in blue with the bottom left corner flipped up into the square in the color of orange. The color white represents a background and is not claimed as a feature of the mark.
Holders and representatives
Holders
Zhejiang Hisun Pharmaceutical Co., Ltd.
Representatives
Zhejiang Hisun Pharmaceutical Co., Ltd.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Analgesics; Cardiovascular pharmaceuticals; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; Placebo pills and mixes for the psychological benefit of cleansing one's karma; Therapeutic agents for weight control and appetite suppression; Tumor suppressing agents; Urinary tract disinfectants
Publications
History of USPTO decisions and trademark events.
15 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/26/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/01/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/01/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/01/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/01/2023
DOCK
ASSIGNED TO EXAMINER
05/17/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/22/2022
NWAP
NEW APPLICATION ENTERED
08/03/2022
Continuous trademark protection
Get notified about every new filing that threatens HISUNUSA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.